Sung|Yun Pai
Sung-Yun Pai, M.D. - Center for Cancer Research
The goal of our research program is to develop tailored cellular therapies for children, adolescents and young adults with genetic diseases ...
Sung-Yun Pai, M.D. | Principal Investigators
Our team is focused on cellular therapy for several disorders, including severe combined immunodeficiency (SCID), Wiskott-Aldrich syndrome (WAS) and DOCK8 ...
Name Sung-Yun Pai, M.D. Current Position Branch Chief, Immune ...
Sung-Yun Pai, M.D.. Current Position. Branch Chief, Immune Deficiency –. Cellular Therapy Program, Center of. Cancer Research, National Cancer. Institute ...
Sung-Yun Pai - National Institutes of Health (NIH) - LinkedIn
Physician-scientist with interest in immunology, hematopoietic stem cell transplantation,… · Experience: National Institutes of Health (NIH): Intramural ...
Sung-Yun Pai, MD, on Further Research With Lentiviral Gene ...
The senior investigator at the National Cancer Institute Center for Cancer Research discussed unmet needs that remain and further research to be done.
Sung-Yun Pai National Institutes of Health | NIH - ResearchGate
Sung-Yun PAI, Senior Investigator | Cited by 10492 | of National Institutes of Health, Bethesda (NIH) | Read 184 publications | Contact Sung-Yun PAI.
Sung-Yun Pai (배성연, 裴晟娟) (@sung_yun_pai) / X
Physician-scientist | Pediatric bone marrow transplanter | Gene therapist | Inborn errors of Immunity | Rare disease | views my own and not my employer.
Sung-Yun Pai, MD, on High T-Cell Reconstitution in X-SCID With ...
Lentiviral gene therapy delivering codon optimized IL2RG resulted in 100% survival and robust T-cell recovery more rapid than after standard ...
Sung-Yun Pai (0000-0002-0158-8147) - ORCID
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II ...
Dr. Sung Yun Pai, MD | Pediatric Hematologist-Oncologist
Dr. Sung Yun Pai is a Pediatric Hematologist-Oncologist in Bethesda, MD. Find Dr. Pai's phone number, address, insurance information and more.
Gene therapy for SCID: Q&A with Dr. Sung-Yun Pai
A. The most important potential risk that is unique to gene therapy is that the vector could insert the gene into cells in such a way that it ...
Immune Deficiency Cellular Therapy Program
Sung-Yun Pai,, is focused on cellular therapy for several disorders, including severe combined immunodeficiency (SCID), Wiskott-Aldrich syndrome (WAS) and ...
Sung-Yun Pai on LinkedIn: So proud and happy that the work of our ...
So proud and happy that the work of our team is out there for world to see. Thank you Boston Children's, National Heart Lung and Blood ...
Senior Researcher. Primary. National Institutes of Health (NIH). Bethesda, United States · Boston Children's Hospital, Harvard Medical School. Boston, United ...
Dr. Sung Yun Pai, MD - Boston, MA - Healthgrades
Dr. Sung Yun Pai, MD is a pediatric hematologist oncologist in Boston, MA and has over 29 years of experience in the medical field.
American physician-scientist and cell biologist.
145 likes, 2 comments - danafarber on May 15, 2017: "Sung-Yun Pai, MD shares a smile with her patient, Levi, who is on a gene therapy trial ...
[email protected] - NIH Clinical Center: Search the Studies
Sung-Yun_Pai,_M.D. ([email protected]). Please provide the following information about yourself in order to expedite a response: Firstname *. Lastname ...
Sung-Yun Pai, Dana-Farber Cancer Institute (IMAGE) - EurekAlert!
This is Sung-Yun Pai, MD, of the Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Credit Courtesy of Dana-Farber/Boston Children's
Pai 2021 - The American Society of Pediatric Hematology/Oncology
2021 Review Course January 27-30, 2021 Sung-Yun Pai, MD Session Title: Immunology and Immunodeficiency Session Duration: 60 minutes